FrancophonIA/ELRC3.0 huggingface dataset:
English: The safety and efficacy of Atripla in children under the age of 18 years have not been established (see section 5.2).
Danish: Pædiatrisk population Atriplas sikkerhed og virkning hos børn og unge under 18 år er ikke klarlagt (se pkt.
English: • feeling weak
Danish: • Svaghedsfølelse
English: Raltegravir/Tenofovir disoproxil (400 mg b.i.d./-)
Danish: Raltegravir/tenofovirdisoproxil (400 mg b.i.d./-)
English: • decreases in phosphate levels in the blood
Danish: • Nedsat indhold af fosfat i blodet
English: This may stop your medicines from working properly, or may make any side effects worse.
Danish: Dette kan betyde, at mængden af Atripla eller anden medicin i blodet kan blive påvirket, og det kan stoppe den hensigtsmæssige virkning af Deres medicin eller forværre evt. bivirkninger.
English: AUC: ↓ 83% (↓ 79 to ↓ 87) Cmax: ↓ 80% (↓ 77 to ↓ 83) Cmin: ↓ 86% (↓ 80 to ↓ 90)
Danish: AUC: ↓ 83% (↓ 79 til ↓ 87) Cmax: ↓ 80% (↓ 77 til ↓ 83) Cmin: ↓ 86% (↓ 80 til ↓ 90)
English: For co-administration of efavirenz with low-dose ritonavir in combination with a protease inhibitor, see section on ritonavir below.
Danish: Mht. samtidig administration af efavirenz og lav-dosis ritonavir i kombination med en protease-hæmmer se afsnittet om ritonavir nedenfor.
English: Study AI266073 was a 48-week open-label randomised clinical study in HIV infected patients comparing the efficacy of Atripla to antiretroviral therapy consisting of at least two nucleoside or nucleotide reverse transcriptase inhibitors (NRTIs) with a protease inhibitor or non-nucleoside reverse transcriptase inhibitor; however not a regimen containing all Atripla components (efavirenz, emtricitabine and tenofovir disoproxil).
Danish: Studiet sammenligner Atriplas virkning med antiretroviral behandling bestående af mindst to nukleosid- eller nukleotid-revers transkriptase-hæmmere (NRTIere) i kombination med en proteasehæmmer eller en non-nukleosid-revers transkriptase-hæmmer; dog ikke en behandling, der indeholder alle Atriplakomponenterne (efavirenz, emtricitabin og tenofovirdisoprozil).
English: Mild-to-moderate rash has been reported with the individual components of Atripla.
Danish: Der er indberettet let til moderat udslæt som følge af de individuelle Atripla-komponenter.
English: Currently available data indicate a trend that in patients on a PI-based antiretroviral regimen the switch to Atripla may lead to a reduction of the response to the therapy (see section 5.1).
Danish: De eksisterende data, antyder, at det kan medføre en reduktion i behandlingsresponsen, når patienter skifter fra en antiretroviral behandling, der er baseret på proteasehæmmere, til Atripla, (se pkt.
English: AUC: ↑ 11% (↑ 5 to ↑ 18) Cmax: ↑ 16% (↑ 6 to ↑ 26) Cmin: ↑ 13% (↑ 1 to ↑ 26)
Danish: AUC: ↑ 11% (↑ 5 til ↑ 18) Cmax: ↑ 16% (↑ 6 til ↑ 26) Cmin: ↑ 13% (↑ 1 til ↑ 26)
English: The increased exposure of tenofovir could potentiate adverse reactions associated with tenofovir disoproxil, including renal disorders.
Danish: Den forøgede tenofovir-eksponering kan forstærke virkningen af bivirkninger ved tenofovirdisoproxil, herunder nyresygdomme.
English: (CYP3A4 induction)
Danish: (CYP3A4-induktion)
English: Insufficient data are available to make a dosing recommendation for indinavir when dosed with Atripla.
Danish: Der er kun utilstrækkelige data til doseringsanbefaling for indinavir, når dette doseres sammen med Atripla.
English: Co-administration of saquinavir/ritonavir and Atripla is not recommended.
Danish: Samtidig administration af saquinavir/ritonavir og Atripla frarådes.
English: Methadone/Emtricitabine
Danish: Methadon/emtricitabin
English: Insufficient data are available to make a dosing recommendation for lopinavir/ritonavir when dosed with Atripla.
Danish: Der er kun utilstrækkelige data tilgængelige til doseringsanbefaling for lopinavir/ritonavir, når dette doseres sammen med Atripla.
English: If therapy with Atripla is discontinued, consideration should be given to the long half-life of efavirenz (see section 5.2) and long intracellular half-lives of emtricitabine and tenofovir.
Danish: Hvis behandling med Atripla seponeres, bør efavirenz' lange halveringstid (se pkt.
English: If Atripla is stopped your doctor may recommend that you resume hepatitis B treatment.
Danish: Hvis behandlingen med Atripla ophører, vil Deres læge muligvis foreslå, at De genoptager behandlingen af hepatitis B. Det kan være nødvendigt at få taget blodprøver i 4 måneder efter ophør med behandlingen for at kontrollere, hvordan Deres lever fungerer.
English: Atovaquone and proguanil hydrochloride/Tenofovir disoproxil
Danish: Atovaquon og proguanilhydrochlorid/ tenofovirdisoproxil
English: Sertraline/Emtricitabine
Danish: Sertralin/emtricitabin
English: Voriconazole/Emtricitabine
Danish: Voriconazole/emtricitabin
English: Film-coating Iron oxide black Iron oxide red Macrogol 3350
Danish: Sort jernoxid Rød jernoxid Macrogol 3350 Poly(vinylalkohol) Talcum
English: Atripla (see earlier in section 2, Do not take Atripla).
Danish: Hvis De har en alvorlig leversygdom, må De ikke tage Atripla (se ovenfor punkt 2, Tag ikke Atripla).
English: Co-administration of Atripla and didanosine is not recommended (see section 4.4).
Danish: Samtidig administration af Atripla og didanosin frarådes (se pkt.
English: The length of combination antiretroviral therapy, corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index, among others, may be some of the many risk factors for developing this disease.
Danish: Til de mange risikofaktorer for udvikling af denne sygdom hører blandt andre: Hvor længe den antiretrovirale kombinationsbehandling varer, anvendelse af kortikosteroider, alkoholforbrug, alvorligt nedsat immunforsvar, samt højere Body Mass Index (BMI).
English: Ethinyloestradiol/Tenofovir disoproxil (-/245 mg q.d.)
Danish: Ethinylestradiol/ tenofovirdisoproxil (-/245 mg q.d.)
English: Atripla and sofosbuvir can be co-administered without dose adjustment.
Danish: Atripla og sofosbuvir kan administreres samtidigt uden dosisjustering
English: - Medicines used to prevent organ transplant rejection (also called immunosuppressants),
Danish: - Medicin, der anvendes til at forhindre afstødning af transplanterede organer (også kaldet immunsuppresiva), såsom ciclosporin, sirolimus eller tacrolimus.
English: Rosuvastatin/Emtricitabine
Danish: Rosuvastatin/emtricitabin
English: AUC: ↑ 21% Cmin: ↑ 17%
Danish: AUC: ↑ 21% Cmin: ↑ 17% Cmax: ↑ 15%
English: AUC: ↑ 21% (↑ 10 to ↑ 34) Cmax: ↑ 14% (↑ 4 to ↑ 26) Cmin: ↑ 25% (↑ 7 to ↑ 46)
Danish: AUC: ↑ 21% (↑ 10 til ↑ 34) Cmax: ↑ 14% (↑ 4 til ↑ 26) Cmin: ↑ 25% (↑ 7 til ↑ 46)
English: Atripla is recommended for administration on an empty stomach since food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 4.8).
Danish: Atripla anbefales til administration på tom mave, da mad kan øge efavirenz-eksponeringen og kan føre til en øget frekvens af bivirkninger (se pkt.
English: Posaconazole/Emtricitabine
Danish: Posaconazol/emtricitabin
English: The pharmacokinetics of Atripla have not been studied in HIV infected patients with hepatic impairment.
Danish: Atriplas farmakokinetik er ikke undersøgt hos hiv-inficerede patienter med nedsat leverfunktion.
English: St. John's wort (Hypericum perforatum): Co-administration of Atripla and St. John's wort or herbal preparations containing St. John's wort is contraindicated.
Danish: Perikon (Hypericum perforatum): Samtidig administration af Atripla og perikon eller naturlægemidler, der indeholder perikon, er kontraindiceret.
English: Discontinuation of Atripla therapy in patients co-infected with HIV and HBV may be associated with severe acute exacerbations of hepatitis (see section 4.4).
Danish: Seponering af Atripla hos patienter, der har både hiv og HBV, kan være forbundet med svær, akut forværring af hepatitis (se pkt.
English: Rare hepatic failure3,4
Danish: Leversvigt3,4
English: In combination studies evaluating the in vitro antiviral activity of efavirenz and emtricitabine together, efavirenz and tenofovir together, and emtricitabine and tenofovir together, additive to synergistic antiviral effects were observed.
Danish: Additiv til synergistiske virkninger blev observeret i kombinationsstudier til vurdering af efavirenz' og emtricitabins samlede antivirale aktivitet in vitro samt emtricitabins og tenofovirs samlede antivirale aktivitet.
English: Cases of acute renal failure after initiation of high dose or multiple non-steroidal anti-inflammatory drugs (NSAIDs) have been reported in patients treated with tenofovir disoproxil and with risk factors for renal dysfunction.
Danish: Hos patienter i behandling med tenofovirdisoproxil med risikofaktorer for renal dysfunktion er der blevet rapporteret tilfælde af akut nyresvigt efter påbegyndelse af højdosis behandling med nonsteroide antiinflammatoriske midler (NSAID'er) og behandling med flere NSAID'er.
English: Dose adjustments of diltiazem when coadministered with Atripla should be guided by clinical response (refer to the Summary of Product Characteristics for diltiazem).
Danish: Når diltiazem administreres samtidigt med Atripla, bør justering af diltiazemdosis styres af klinisk respons (se produktresumé for diltiazem).
English: Darunavir/ritonavir/Tenofovir disoproxil (300 mg b.i.d.
Danish: Darunavir/ritonavir/ tenofovirdisoproxil (300 mg b.i.d.
English: AUC: ↑ 98% (↑ 77 to ↑ 123) Cmax: ↑ 79% (↑ 56 to ↑ 104) Cmin: ↑ 163% (↑ 137 to ↑ 197)
Danish: AUC: ↑ 98% (↑ 77 til ↑ 123) Cmax: ↑ 79% (↑ 56 til ↑ 104) Cmin: ↑ 163% (↑ 137 til ↑ 197)
English: AUC: ↓ 4% (↓ 0 to ↓ 31) Cmax: ↓ 47% (↓ 9 to ↓ 51)
Danish: AUC: ↓ 4% (↓ 0 til ↓ 31) Cmax: ↓ 47% (↓ 9 til ↓ 51)
English: LIPID LOWERING MEDICINAL PRODUCTS HMG Co-A Reductase Inhibitors Atorvastatin/Efavirenz (10 mg q.d./600 mg q.d.)
Danish: LIPIDSÆNKENDE LÆGEMIDLER HMG Co-A Reduktasehæmmere Atorvastatin/efavirenz (10 mg q.d./600 mg q.d.)
English: AUC: ↓ 35% (↓ 13 to ↓ 40) Cmax: ↓ 13% (↓ 0 to ↓ 23)
Danish: AUC: ↓ 35% (↓ 13 til ↓ 40) Cmax: ↓ 13% (↓ 0 til ↓ 23)
English: Dosage adjustment of lopinavir/ritonavir is necessary when given with efavirenz.
Danish: Justering af lopinavir-/ritonavirdosis er nødvendig ved administration sammen med efavirenz.
English: Fluoxetine/Emtricitabine
Danish: Fluoxetin/emtricitabin
English: Switching from a PI-based antiretroviral regimen
Danish: Ved skift fra en antiretroviral behandling, der er baseret på proteasehæmmere
English: Vascular disorders: Uncommon flushing
Danish: Vaskulære sygdomme: Ikke almindelig
English: AUC: ↓ 69% (↓ 62 to ↓ 73) Cmax: ↓ 76% (↓ 63 to ↓ 79)
Danish: AUC: ↓ 69% (↓ 62 til ↓ 73) Cmax: ↓ 76% (↓ 63 til ↓ 79)
English: Convulsions have been observed in patients receiving efavirenz, generally in the presence of a known medical history of seizures.
Danish: Der er set krampeanfald hos patienter i efavirenzbehandling, sædvanligvis i forbindelse med kramper i anamnesen.
English: Efavirenz/emtricitabine/tenofovir disoproxil
Danish: Efavirenz/emtricitabin/tenofovirdisoproxil
English: If a patient misses a dose of Atripla by more than 12 hours and it is almost time for the next dose, the patient should not take the missed dose and simply resume the usual dosing schedule.
Danish: og det næsten er tid til næste dosis, skal patienten ikke tage den manglende dosis, men blot fortsætte med den normale doseringsplan.
English: Didanosine/Efavirenz
Danish: Didanosin/efavirenz
English: AUC: ↓ 60% (↓ 52 to ↓ 68) Cmax: ↓ 62% (↓ 55 to ↓ 78)
Danish: AUC: ↓ 60% (↓ 52 til ↓ 68) Cmax: ↓ 62% (↓ 55 til ↓ 78)
English: AUC12h: ↔ Cmax: ↔
Danish: AUC12t: ↔ Cmax: ↔
English: CCR5 antagonist Maraviroc/Efavirenz (100 mg b.i.d./600 mg q.d.)
Danish: CCR5-antagonister Maraviroc/efavirenz (100 mg b.i.d./600 mg q.d.)
English: It is recommended that Atripla be taken on an empty stomach since food may increase efavirenz exposure and may lead to an increase in the frequency of adverse reactions (see sections 4.4 and 4.8).
Danish: Det anbefales, at Atripla tages på tom mave, da mad kan øge efavirenz-eksponeringen og kan føre til øget bivirkningsfrekvens (se pkt.
English: Methadone/Tenofovir disoproxil (40-110 mg q.d./245 mg q.d.)
Danish: Methadon/tenofovirdisopoxil (40-110 mg q.d./245 mg q.d.)
English: Cmax: ↓ 64% (↓ 57 to ↓ 69) Cmin: ↓ 62% (↓ 44 to ↓ 75)
Danish: Cmax: ↓ 64% (↓ 57 til ↓ 69) Cmin: ↓ 62% (↓ 44 til ↓ 75)
English: Reproductive system and breast disorders: Uncommon gynaecomastia
Danish: Det reproduktive system og mammae: Ikke almindelig
English: Each film-coated tablet contains 600 mg of efavirenz, 200 mg of emtricitabine and 245 mg of tenofovir disoproxil (as fumarate).
Danish: Hver filmovertrukket tablet indeholder 600 mg efavirenz, 200 mg emtricitabin og 245 mg tenofovirdisoproxil (som fumarat).
English: Saquinavir/ritonavir/Emtricitabine
Danish: Saquinavir/ritonavir/emtricitabin
English: AUC: ↓ 39% (↓ 30 to ↓ 46) Cmax: ↓ 26% (↓ 15 to ↓ 35)
Danish: AUC: ↓ 39% (↓ 30 til ↓ 46) Cmax: ↓ 26% (↓ 15 til ↓ 35)
English: Immune system disorders: Common allergic reaction
Danish: Immunsystemet: Almindelig
English: AUC: ↓ 58% (↓ 39 to ↓ 68) Cmax: ↓ 51% (↓ 32 to ↓ 58)
Danish: AUC: ↓ 58% (↓ 39 til ↓ 68) Cmax: ↓ 51% (↓ 32 til ↓ 58)
English: which may be allergic reactions
Danish: Allergisk reaktion
English: Itraconazole/Emtricitabine
Danish: Itraconazol/emtricitabin
English: The following side effects are very common (these may affect more than 1 in 10 patients)
Danish: De følgende bivirkninger er meget almindelige (de kan påvirke flere end 1 ud af 10 patienter):
English: Didanosine: Co-administration of Atripla and didanosine is not recommended (see section 4.4 and Table 1).
Danish: Didanosin: Samtidig administration af Atripla og didanosin frarådes (se pkt.
English: - any signs of skin rash.
Danish: Tegn på hududslæt.
English: Atripla and fluoxetine can be co-administered without dose adjustment.
Danish: Atripla og fluoxetin kan administreres uden dosisjustering.
English: • pain in the abdomen (stomach), caused by inflammation of the pancreas
Danish: • Mavesmerter fremkaldt af betændelse i bugspytkirtlen
English: Tacrolimus/Emtricitabine/Tenofovir disoproxil (0.1 mg/kg q.d./200 mg/245 mg q.d.)
Danish: Tacrolimus/emtricitabin/ tenofovirdisoproxil (0,1 mg/kg q.d./200 mg/245 mg q.d.)
English: The following side effects are rare (these may affect up to 1 in every 1,000 patients):
Danish: De følgende bivirkninger er sjældne (de kan påvirke op til 1 ud af hver 1.000 patienter):
English: Dose adjustments of calcium channel blockers when co-administered with Atripla should be guided by clinical response (refer to the Summary of Product Characteristics for the calcium channel blocker).
Danish: Dosisjustering af calciumantagonister, når disse administreres samtidigt med Atripla, bør styres af klinisk respons (se produktresuméet for calciumantagonisten).
English: The following side effects are uncommon (these may affect up to 1 in every 100 patients):
Danish: De følgende bivirkninger er ikke almindelige (de kan påvirke op til 1 ud af hver 100 patienter):
English: Co-administration of Atripla and didanosine is not recommended since exposure to didanosine is significantly increased following co-administration with tenofovir disoproxil that may increase the risk of didanosine-related adverse reactions (see section 4.5).
Danish: Samtidig administration af Atripla og didanosin frarådes, da didanosin-eksponeringen øges signifikant efter samtidig administration af tenofovirdisoproxil (se pkt.
English: Selective Serotonin Reuptake Inhibitors (SSRIs) Sertraline/Efavirenz (50 mg q.d./600 mg q.d.)
Danish: Selektive serotonin-reuptake-hæmmere (SSRIer) Sertralin/efavirenz (50 mg q.d./600 mg q.d.)
English: AUC: ↓ 75% (↓ 62 to ↓ 84) Cmax: ↓ 44% (↓ 20 to ↓ 61)
Danish: AUC: ↓ 75% (↓ 62 til ↓ 84) Cmax: ↓ 44% (↓ 20 til ↓ 61)
English: Eye disorders: Uncommon vision blurred
Danish: Øjne: Ikke almindelig
English: • blurred vision
Danish: • Ansigtsrødme
English: AUC: ↓ 69% (↓ 55 to ↓ 79) Cmax: ↓ 60% (↓ 50 to ↓ 68) Cmin: ↓ 63% (↓ 44 to ↓ 75)
Danish: AUC: ↓ 69% (↓ 55 til ↓ 79) Cmax: ↓ 60% (↓ 50 til ↓ 68) Cmin: ↓ 63% (↓ 44 til ↓ 75)
English: Maraviroc/Tenofovir disoproxil (300 mg b.i.d./245 mg q.d.)
Danish: Maraviroc/tenofovirdisoproxil (300 mg b.i.d./245 mg q.d.)
English: Lopinavir/ritonavir/Tenofovir disoproxil (400 mg b.i.d./100 mg b.i.d./245 mg q.d.)
Danish: Lopinavir/ritonavir/ tenofovirdisoproxil (400 mg b.i.d./100 mg b.i.d./245 mg q.d.)
English: Indinavir/Emtricitabine (800 mg q8h/200 mg q.d.)
Danish: Indinavir/emtricitabin (800 mg q8t/200 mg q.d.)
English: Simvastatin/Emtricitabine
Danish: Simvastatin/emtricitabin
English: AUC: ↓ 52% (↓ 33 to ↓ 66) Cmax: ↓ 45% (↓ 25 to ↓ 59)
Danish: AUC: ↓ 52% (↓ 33 til ↓ 66) Cmax: ↓ 45% (↓ 25 til ↓ 59)
English: AUC12h: ↓ 45% (↓ 38 to ↓ 51) Cmax: ↓ 51% (↓ 37 to ↓ 62)
Danish: AUC12t: ↓ 45% (↓ 38 til ↓ 51) Cmax: ↓ 51% (↓ 37 til ↓ 62)
English: Rifabutin/Emtricitabine
Danish: Rifabutin/emtricitabin
English: Clarithromycin/Tenofovir disoproxil
Danish: Clarithromycin/ tenofovirdisoproxil
English: Simeprevir/Tenofovir disoproxil (150 mg q.d./245 mg q.d.)
Danish: Simeprevir/tenofovirdisoproxil (150 mg q.d./245 mg q.d.)
English: AUC: ↓ 64% (↓ 62 to ↓ 67) Cmax: ↓ 46% (↓ 39 to ↓ 52) Cmin: ↓ 82% (↓ 79 to ↓ 85)
Danish: AUC: ↓ 64% (↓ 62 til ↓ 67) Cmax: ↓ 46% (↓ 39 til ↓ 52) Cmin: ↓ 82% (↓ 79 til ↓ 85)
English: AUC: ↓ 39% (↓ 21 to ↓ 53) Cmax: ↓ 37% (↓ 20 to ↓ 51) Cmin: ↓ 44% (↓ 27 to ↓ 58)
Danish: AUC: ↓ 39% (↓ 21 til ↓ 53) Cmax: ↓ 37% (↓ 20 til ↓ 51) Cmin: ↓ 44% (↓ 27 til ↓ 58)
English: Atazanavir/ritonavir/Emtricitabine
Danish: Atazanavir/ritonavir/emtricitabin
English: AUC: ↔ Cmax: ↔ C24h: ↔
Danish: AUC: ↔ Cmax: ↔ C24t: ↔
English: Methadone/Efavirenz (35-100 mg q.d./600 mg q.d.)
Danish: Methadon/efavirenz (35-100 mg q.d./600 mg q.d.)
English: Bupropion/Emtricitabine
Danish: Bupropion/emtricitabin
English: Co-administration of atazanavir/ritonavir and Atripla is not recommended.
Danish: Samtidig administration af atazanavir/ritonavir og Atripla frarådes.
English: Etonogestrel/Tenofovir disoproxil
Danish: Etonogestrel/ tenofovirdisoproxil
English: Carbamazepine/Emtricitabine
Danish: Carbamazepin/emtricitabin
English: Indinavir/Tenofovir disoproxil (800 mg q8h/245 mg q.d.)
Danish: Indinavir/tenofovirdisoproxil (800 mg q8t/245 mg q.d.)
English: AUC: ↓ 55% (↓ 48 to ↓ 62) Cmax: ↓ 34% (↓ 21 to ↓ 47)
Danish: AUC: ↓ 55% (↓ 48 til ↓ 62) Cmax: ↓ 34% (↓ 21 til ↓ 47)
English: 300 mg/ritonavir 100 mg q.d.
Danish: * Ved sammenligning med atazanavir 300 mg/ritonavir 100 mg q.d.
English: Renal impairment: As Atripla may cause renal damage, monitoring of renal function is recommended (see sections 4.4 and 4.8 Summary of the safety profile).
Danish: Nedsat nyrefunktion: Da Atripla kan forårsage nyreskader, anbefales monitorering af nyrefunktionen (se pkt.
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./200 mg q.d./600 mg q.d., all administered with food)
Danish: Atazanavir/ritonavir/efavirenz (400 mg q.d./200 mg q.d./600 mg q.d., alle administreret sammen med mad)
English: Rifampicin/Emtricitabine
Danish: Rifampicin/emtricitabin
English: Ritonavir/Emtricitabine
Danish: Ritonavir/emtricitabin
English: AUC: ↓ 10% C12h: ↓ 13% Cmax: ↓ 23%
Danish: AUC: ↓ 10% C12t: ↓ 13% Cmax: ↓ 23%
English: AUC: ↓ 36% C12h: ↓ 21% Cmax: ↓ 36%
Danish: AUC: ↓ 36% C12t: ↓ 21% Cmax: ↓ 36%
English: AUC: ↓ 37% (↓ 14 to ↓ 55) Cmax: ↓ 35% (↓ 12 to ↓ 52) Cmin: ↓ 43% (↓ 18 to ↓ 60)
Danish: AUC: ↓ 37% (↓ 14 til ↓ 55) Cmax: ↓ 35% (↓ 12 til ↓ 52) Cmin: ↓ 43% (↓ 18 til ↓ 60)
English: Atripla should be administered with caution to patients with mild hepatic impairment (see sections 4.3 and 4.4).
Danish: Atripla bør administreres med forsigtighed til patienter med let nedsat leverfunktion (se pkt.
English: AUC: ↓ 34% (↓ 21 to ↓ 41) Cmax: ↓ 20% (↓ 2 to ↓ 26)
Danish: AUC: ↓ 34% (↓ 21 til ↓ 41) Cmax: ↓ 20% (↓ 2 til ↓ 26)
English: Atorvastatin/Emtricitabine
Danish: Atorvastatin/emtricitabin
English: Although the etiology is considered to be multifactorial (including corticosteroid use, alcohol consumption, severe immunosuppression, higher body mass index), cases of osteonecrosis have been reported particularly in patients with advanced HIV disease and/or long-term exposure to CART.
Danish: Ætiologien anses dog for at være multifaktoriel (omfattende anvendelse af kortikosteroider, alkoholforbrug, svær immunosuppression, højere Body Mass Index (BMI)).
English: Atripla and fosamprenavir/ritonavir can be co-administered without dose adjustment.
Danish: Atripla og fosamprenavir/ritonavir kan administreres samtidigt uden dosisjustering.
English: Atripla and paroxetine can be co-administered without dose adjustment.
Danish: Atripla og paroxetin kan administreres uden dosisjustering.
English: Buprenorphine/naloxone/Tenofovir disoproxil
Danish: Buprenorphin/naloxon/ tenofovirdisoproxil
English: Atripla and raltegravir can be co-administered without dose adjustment.
Danish: Atripla og raltegravir kan administreres samtidigt uden dosisjustering.
English: If you take more Atripla than you should
Danish: Hvis De har taget for meget Atripla
English: Diltiazem/Tenofovir disoproxil
Danish: Diltiazem/tenofovirdisoproxil
English: AUC: ↓ 43% (↓ 34 to ↓ 50) Cmax: ↓ 12% (↓ 1 to ↓ 26)
Danish: AUC: ↓ 43% (↓ 34 til ↓ 50) Cmax: ↓ 12% (↓ 1 til ↓ 26)
English: AUC: ↓ 27% (↓ 20 to ↓ 33) Cmax: ↓ 20% (↓ 15 to ↓ 24) Cmin: ↓ 35% (↓ 24 to ↓ 44)
Danish: AUC: ↓ 27% (↓ 20 til ↓ 33) Cmax: ↓ 20% (↓ 15 til ↓ 24) Cmin: ↓ 35% (↓ 24 til ↓ 44)
English: AUC: ↓ 39% (↓ 27 to ↓ 50) Cmax: ↓ 29% (↓ 15 to ↓ 40) Cmin: ↓ 46% (↓ 31 to ↓ 58)
Danish: AUC: ↓ 39% (↓ 27 til ↓ 50) Cmax: ↓ 29% (↓ 15 til ↓ 40) Cmin: ↓ 46% (↓ 31 til ↓ 58)
English: Atazanavir/ritonavir/Efavirenz (400 mg q.d./100 mg q.d./600 mg q.d., all administered with food)
Danish: Atazanavir/ritonavir/efavirenz (400 mg q.d./100 mg q.d./600 mg q.d., alle administreret sammen med mad)
English: Paroxetine/Emtricitabine
Danish: Paroxetin/emtricitabin
English: Bone effects
Danish: Virkning på knogler
English: AUC: ↓ 36% (↓ 32 to ↓ 40) Cmax: ↓ 21% (↓ 15 to ↓ 26) Cmin: ↓ 47% (↓ 41 to ↓ 53)
Danish: AUC: ↓ 36% (↓ 32 til ↓ 40) Cmax: ↓ 21% (↓ 15 til ↓ 26) Cmin: ↓ 47% (↓ 41 til ↓ 53)
English: Rifampicin/Tenofovir disoproxil (600 mg q.d./245 mg q.d.)
Danish: Rifampicin/tenofovirdisoproxil (600 mg q.d./245 mg q.d.)
English: Patients with moderate or severe renal impairment require a dose adjustment of emtricitabine and tenofovir disoproxil that cannot be achieved with the combination tablet (see sections 4.2 and 5.2).
Danish: Hos patienter med moderat eller svær nedsat nyrefunktion er det nødvendigt med justering af emtricitabin- og tenofovirdisoproxildosis, som ikke kan opnås med kombinationstabletten (se pkt.
English: AUC: ↓ 38% (↓ 28 to ↓ 47) Cmax: ↓ 32% (↓ 15 to ↓ 46) Cmin: ↓ 45% (↓ 31 to ↓ 56)
Danish: AUC: ↓ 38% (↓ 28 til ↓ 47) Cmax: ↓ 32% (↓ 15 til ↓ 46) Cmin: ↓ 45% (↓ 31 til ↓ 56)
English: Boceprevir/Efavirenz (800 mg q8h/600 mg q.d.)
Danish: Boceprevir/efavirenz (800 mg q8t/600 mg q.d.)
English: Fosamprenavir/ritonavir/Tenofovir disoproxil
Danish: Fosamprenavir/ritonavir/ tenofovirdisoproxil
English: Saquinavir/ritonavir/Tenofovir disoproxil There were no clinically significant pharmacokinetic interactions when tenofovir disoproxil was co-administered with ritonavir boosted saquinavir.
Danish: Der var ingen klinisk signifikante farmakokinetiske interaktioner, når tenofovirdisoproxil blev administreret samtidig med saquinavir forstærket med ritonavir.
English: - This medicine has been prescribed for you only.
Danish: - Lægen har ordineret Atripla til Dem personligt.
English: AUC: ↓ 26% (↓ 15 to ↓ 36) Cmax: ↓ 20% (↓ 11 to ↓ 28) Cmin: ↓ 32% (↓ 15 to ↓ 46)
Danish: AUC: ↓ 26% (↓ 15 til ↓ 36) Cmax: ↓ 20% (↓ 11 til ↓ 28) Cmin: ↓ 32% (↓ 15 til ↓ 46)
English: Darunavir/ritonavir/Emtricitabine
Danish: Darunavir/ritonavir/emtricitabin
English: Sertraline/Tenofovir disoproxil
Danish: Sertralin/tenofovirdisoproxil
English: Dosage adjustments of atorvastatin may be required when co-administered with Atripla (refer to the Summary of Product Characteristics for atorvastatin).
Danish: Justering af atorvastatindosis kan være nødvendig, når det administreres samtidigt med Atripla (se produktresuméet for atorvastatin).